ArticleCells2025

Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions.

Shubhasmita Mohapatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.